A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers
Status:
Completed
Trial end date:
2020-02-12
Target enrollment:
Participant gender:
Summary
This is a single-centre, blinded, randomized, placebo controlled, dose escalation study. Up
to 9 healthy male volunteers will participate in the study. This study is designed to
investigate the use of delayed release tablets for colonic delivery of Brilacidin.